MedPath

ESPIRONOLACTONA ALTER 25 mg COMPRIMIDOS RECUBIERTOS EFG

ESPIRONOLACTONA ALTER 25 mg COMPRIMIDOS RECUBIERTOS EFG

Commercialized
Register Number

63835

Prescription Type

Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración

Authorization Date

Apr 18, 2001

Dosage Form

COMPRIMIDO RECUBIERTO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number63835
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

ESPIRONOLACTONAActive
Quantity: 25 mg
Name: ESPIRONOLACTONA

ATC CLASSIFICATION (3)

C03D
C03DA
C03DA01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.